The civic record
Read. Follow. Verify.Missouri House Bill 2349 Updates Rules for Epinephrine Delivery Devices in Schools, Fire Districts, and Public Entities
Last action · February 5, 2026: HCS Reported Do Pass (H)Sponsors: Sherri Gallick and 1 other
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
House Bill 2349 modifies state statutes regarding s by updating terminology, establishing civil liability protections for authorized entities and trained personnel, requiring basic life support ambulances and stretcher vans to be equipped with the devices, and creating a dedicated state fund for fire personnel. The measure details possession, storage, training, and emergency reporting requirements for schools, authorized public organizations, and first responders.
Schools, authorized public organizations, ambulance services, and fire protection districts must follow updated statutory protocols for storing, maintaining, and administering epinephrine devices, while gaining specific civil liability protections for trained staff rendering emergency treatment.
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
School Pupils
Pupils with chronic health conditions are granted statutory authorization to possess and self-administer prescribed medication at school and school-sponsored activities.
School Boards and School Nurses
School boards may maintain supplies of epinephrine delivery devices via prescriptions, and school nurses or trained employees are authorized to administer them during emergencies.
Authorized Entities
Organizations such as youth sports leagues, child care facilities, and restaurants may acquire, stock, and administer epinephrine devices under specific storage and training guidelines.
Ambulance Services and Stretcher Vans
All basic life support ambulances and stretcher vans must be equipped with epinephrine delivery devices and staffed by at least one trained individual.
Key Facts
- Pupils with chronic health conditions such as asthma or anaphylaxis are authorized to possess and self-administer medication in school, at school-sponsored activities, and in transit, provided specific physician, parent, and school documentation and liability statements are met.
- School boards may authorize a licensed school nurse to maintain an adequate supply of epinephrine delivery devices obtained via a prescription designating the school district as the patient.
- School nurses, contracted agents, or trained employees have the discretion to use an epinephrine delivery device on any student believed to be having a life-threatening anaphylactic reaction.
- Authorized entities such as restaurants, recreation camps, youth sports leagues, child care facilities, amusement parks, and sports arenas may acquire and stock a supply of epinephrine delivery devices under a prescription.
Show all 8 facts
- No person shall provide or administer an epinephrine delivery device to an individual under eighteen years of age without parental verbal consent, unless the parent is absent and the individual is reasonably believed to be in imminent danger.
- Authorized entities, administering persons, and prescribing physicians are granted civil immunity from ordinary negligence for injuries resulting from the administration or self-administration of epinephrine delivery devices in accordance with the law.
- All basic life support ambulances and stretcher vans operated in the state must be equipped with epinephrine delivery devices and staffed by at least one trained individual.
- The bill creates the 'Epinephrine Delivery Devices for Fire Personnel Fund' in the state treasury to be used solely by the department of health and senior services for providing devices to qualified first responder agencies.
Frequently Asked Questions
Can a student carry and self-administer an epinephrine device at school?
Are schools and authorized entities protected from civil liability?
What organizations qualify as an 'authorized entity' to stock epinephrine devices?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently in committee. The next step in the legislative lifecycle is Floor Vote.
Procedural history
8 actions- Feb 5, 2026HouseCommitteeHCS Reported Do Pass (H)
- Feb 5, 2026HouseCommitteeHCS Voted Do Pass (H)
- Feb 5, 2026HouseExecutive Session Completed (H)
- Jan 29, 2026HousePublic Hearing Completed (H)
- Jan 8, 2026HouseCommitteeReferred: Health and Mental Health(H)
- Jan 8, 2026HouseFloorRead Second Time (H)
Show 2 earlier actions
- Jan 7, 2026HouseIntroducedRead First Time (H)
- Dec 10, 2025HouseIntroducedPrefiled (H)
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Connected Entities
Sources
house.mo.gov
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy15Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz30Current news / social attention level
Publisher tools